Abstract
One of the most prevalent neurodegenerative diseases worldwide is still referred to as 'Parkinson's disease'. The condition is named after James Parkinson who, in 1817, described the shaking palsy (paralysis agitans). In the bicentennial year of this publication, we trace when and why the shaking palsy became Parkinson's disease. The term was coined by William Rutherford Sanders of Edinburgh in 1865 and later entered general usage through the influence of Jean-Martin Charcot and the school that he nurtured at the Salpêtrière Hospital in Paris. Despite a move towards more mechanism-based nosology for many medical conditions in recent years, the Parkinson's disease eponym remains in place, celebrating the life and work of this doctor, palaeontologist and political activist.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
Nano-Micro Letters Open Access 15 April 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Willis, T. in De Anima Brutorum 392–432 (R. Davis, 1672).
Oxford Univ. Press in Compact Oxford English Dictionary Vol. 2 2061 (Oxford Univ. Press, 1971).
Parkinson, J. An Essay on the Shaking Palsy (Whittingham and Rowland, 1817).
Ars-Berättelse om Svenska Läkare-Sällskapets Arbeten 91 (Stockholm, 1817).
Cooke, J. in A Treatise on Nervous Diseases. History and Method of Cure of the Various Species of Palsy. Vol. 2 207 (Longman, 1821).
Hall, M. in On the Diseases and Derangements of the Nervous System, in their Primary Forms and in their Modifications by Age, Sex, Constitution, Hereditary Predisposition, Excesses, General Disorder, and Organic Disease 320 (Baillière, 1841).
Sanders, W. R. Case of an unusual form of nervous disease, dystaxia or pseudo-paralysis agitans, with remarks. Edinb. Med. J. 10, 987–997 (1865).
Louis, E. D. The shaking palsy, the first forty-five years: a journey through the British literature. Mov. Disord. 12, 1068–1072 (1997).
Lewis, C. The Enlightened Mr. Parkinson: the Pioneering Life of a Forgotten English Surgeon (Icon Books Ltd, 2017).
Hurwitz, B. Parkinson's disease: what's in the name? Lancet 389, 2098–2099 (2017).
Rowntree, L. G. James Parkinson MD. Bull. Johns Hopkins Hosp. 23, 33–45 (1912).
McMenemy, W. H. in James Parkinson (1755–1824) (ed. Critchley, M.) 1–143 (Macmillan, 1955).
Gardner-Thorpe, C. James Parkinson (Royal Devon and Exeter Hospital, 1987).
Morris, A. D. James Parkinson: His Life and Times (Birkhäuser Boston, 1989).
[No authors listed.] Obituary of William Rutherford Sanders. Br. Med. J. 1, 321–322 (1881).
Comrie, J. D. in History of Scottish Medicine Vol. 2 697 (Wellcome Historical Medical Museum, 1932).
Sanders, W. R. in In A System of Medicine Vol. 2 (ed. Reynolds, J. R.) 184–204 (Macmillan, 1868).
Putnam, T. J. Athetosis. Yale J. Biol. Med. 11, 459–465 (1939).
Fereshtehnejad, S. M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain 140, 1959–1976 (2017).
Goetz, C. G., Bonduelle, M. & Gelfand, T. Charcot: Constructing Neurology (Oxford Univ. Press, 1995).
Charcot, J.-M. & Vulpian, A. De la paralysie agitante. A propos d'un cas tiré de la clinique du Professeur Oppolzer [French]. Gaz. Hebdom. Méd. Chir. 8, 765–767; 8, 816–820; 9, 54–59 (1861/1862).
Charcot, J.-M. Leçons du Mardi à la Salpêtrière. Professeur Charcot. Policlinique 1887–1888. Notes de Cours de MM. Blin, Charcot et H. Colin [French] (Aux Bureaux du Progrès Médical, 1887).
Goetz, C. G. Charcot the Clinician: the Tuesday Lessons: Excerpts from Nine Case Presentations on General Neurology Delivered at the Salpêtrière Hospital in 1887–1888 (Raven Press, 1987).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 1 (Delahaye, 1872/1873).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 2 (Aux Bureaux du Progrès Médical and Delahaye, 1877).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par MM. Babinski, Bernard, Féré, Guinon, Marie et Gilles de la Tourette [French] Vol. 3 (Aux Bureaux du Progrès Médical, 1887).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 1 2nd edn (Delahaye & Co., 1875).
Charcot, J.-M. Lectures on the Diseases of the Nervous System delivered at la Salpêtrière by J.-M. Charcot. Translated by George Sigerson (New Sydenham Society, 1877).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 1 3rd edn (Delahaye & Co., 1877).
Bourneville, D. M. Du tremblement dans la maladie de Parkinson (paralysie agitante) [French]. Progrès Méd. 4, 838–840 (1876).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 1 4th edn (Delahaye and Lecrosnier, 1880).
Charcot, J.-M. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière par J.-M. Charcot. Recueillies et publiées par Bourneville [French] Vol. 1 5th edn (Delahaye, 1884).
Charcot, J.-M. Lectures on the Diseases of the Nervous System delivered at the Infirmary of la Salpêtrière by J.-M. Charcot, Vol. 3. Translated by Thomas Savill (New Sydenham Society, 1889).
Charcot, J.-M. Leçons du Mardi à la Salpêtrière Professeur Charcot. Policlinique 1888–1889. Notes de Cours de MM. Blin, Charcot, Henri Colin [French] (Aux Bureaux du Progrès Médical, Lecrosnier and Babé, 1888/1889).
Goetz, C. G. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb. Perspect. Med. 1, a008862 (2011).
Lees, A. An essay on the shaking palsy. Brain 140, 843–848 (2017).
Blocq, P. & Marinesco, G. Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tumeur du pédoncule cérébral [French]. C. R. Soc. Biol. 5, 105–111 (1893).
Benedikt, M. Tremblement avec paralysie croisée du moteur oculaire commun [French]. Bull. Méd. 3, 547–548 (1889).
Brissaud, E. Leçons sur les Maladies Nerveuses Recueillies et publiées par Henry Meige [French] (Masson, 1895).
Trétiakoff, C. Contribution à l'étude de l'Anatomie pathologique du Locus Niger [French] (Jouve & Co., 1919).
Lees, A. J., Selikhova, M., Andrade, L. A. & Duyckaerts, C. The black stuff and Konstantin Nikolaevich Tretiakoff. Mov. Disord. 23, 777–783 (2008).
Lewy, F. in In Handbuch der Neurologie [German] Vol. 3. (eds Lewandowsky, M. & Abelsdorff, G.) 920–933 (Springer, 1912).
Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13–24 (2013).
Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
von Economo, C. Die Encephalitis lethargica, ihre Nachkrankheiten und ihre Behandlung [German] (Urban & Schwarzenberg, 1929).
Sicard, J. A. & Paraf, J. Parkinsonnisme et Parkinson, reliquats d'encéphalite épidémique [French]. Rev. Neurol. 36, 465–470 (1920).
Buée-Scherrer, V. et al. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Ann. Neurol. 42, 356–359 (1997).
Josephs, K. A., Parisi, J. E. & Dickson, D. W. Alpha-synuclein studies are negative in postencephalitic parkinsonism of von Economo. Neurology 59, 645–646 (2002).
McWilliams, T. G. & Muqit, M. M. PINK1 and Parkin: emerging themes in mitochondrial homeostasis. Curr. Opin. Cell Biol. 45, 83–91 (2017).
Doherty, K. M. et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 70, 571–579 (2013).
Berg, D. et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov. Disord. 29, 454–462 (2014).
Acknowledgements
The authors thank G. Delaunay from the Bibliothèque Charcot (Hôpital de la Pitié Salpêtrière) as well as M.-C. Potier and C. Duyckaerts from the Institut du Cerveau et de la Moelle Epinière (Hôpital de la Pitié Salpêtrière) for their help.
Author information
Authors and Affiliations
Contributions
Both authors researched data for the article, discussed the content, wrote the article, and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
DATABASES
Rights and permissions
About this article
Cite this article
Goedert, M., Compston, A. Parkinson's disease — the story of an eponym. Nat Rev Neurol 14, 57–62 (2018). https://doi.org/10.1038/nrneurol.2017.165
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2017.165
This article is cited by
-
Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes
Molecular Neurobiology (2023)
-
Research process, recap, and prediction of Chiari malformation based on bicentennial history of nomenclature and terms misuse
Neurosurgical Review (2023)
-
Repositioning the existing drugs for neuroinflammation: a fusion of computational approach and biological validation to counter the Parkinson’s disease progression
Molecular Diversity (2023)
-
Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role
Pharmacological Reports (2022)
-
Metformin improves depressive-like behavior in experimental Parkinson’s disease by inducing autophagy in the substantia nigra and hippocampus
Inflammopharmacology (2022)